In a 25-year-old man with resistant hypertension, hypokalemia, metabolic alkalosis, and a family history of stroke, which investigation is appropriate to evaluate the cause of his uncontrolled blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Renin-Aldosterone Ratio (Answer A)

In this 25-year-old man with resistant hypertension, hypokalemia, and metabolic alkalosis, you should order a renin-angiotensin ratio (plasma aldosterone-renin ratio, ARR) to screen for primary aldosteronism, which is the most likely diagnosis and the most common cause of secondary hypertension in this clinical scenario 1, 2.

Clinical Reasoning

This patient presents with the classic triad of primary aldosteronism:

  • Resistant hypertension (uncontrolled on two medications at age 25)
  • Hypokalemia (low potassium)
  • Metabolic alkalosis (low bicarbonate/low pH suggests this, though typically pH would be elevated in alkalosis)

The combination of young age, resistant hypertension, and spontaneous hypokalemia makes primary aldosteronism highly likely, with prevalence reaching 17.8% in young-onset hypertension and 20-30% in resistant hypertension 2.

Why Renin-Aldosterone Ratio First

The 2025 Endocrine Society guidelines explicitly recommend ARR as the primary screening tool for primary aldosteronism in patients with resistant hypertension and/or hypokalemia 1. The ARR will show:

  • Elevated aldosterone (typically >15 ng/dL by LC-MS/MS or >20 ng/dL by immunoassay)
  • Suppressed renin (PRA <0.2 ng/mL/h or DRC <2 mU/L)

This pattern confirms autonomous aldosterone production independent of the renin-angiotensin system 3, 4.

Why Not the Other Options

Options B, C, and D (metanephrines and catecholamines) are used to screen for pheochromocytoma, which typically presents with:

  • Episodic hypertension (not sustained resistant hypertension)
  • Paroxysmal symptoms (headaches, palpitations, sweating)
  • Hypokalemia is NOT a feature of pheochromocytoma

The presence of hypokalemia with metabolic alkalosis essentially rules out pheochromocytoma as the primary diagnosis and points directly toward mineralocorticoid excess (primary aldosteronism) 5.

Important Caveats

  • Medication interference: Beta-blockers and centrally acting alpha-2 agonists can suppress renin and cause false-positive ARR results. If the patient is on these medications, consider repeating the test after 2-week withdrawal if safe 1.
  • Potassium correction: Ideally, correct hypokalemia before testing, as low potassium can suppress aldosterone secretion and cause false-negative results 6.
  • Confirmatory testing: If ARR is positive but aldosterone levels are intermediate (5-15 ng/dL), confirmatory testing with saline infusion test or other suppression tests may be needed 1.

Next Steps After Positive ARR

Once primary aldosteronism is confirmed:

  1. Adrenal CT imaging to identify unilateral adenoma vs bilateral hyperplasia
  2. Adrenal venous sampling if surgical candidate to lateralize aldosterone production
  3. Treatment: Unilateral adenoma → surgical adrenalectomy; bilateral disease → mineralocorticoid receptor antagonists (spironolactone/eplerenone) 1, 3

The family history of stroke is particularly concerning, as untreated primary aldosteronism carries significantly increased cardiovascular risk, including stroke, with MACE rates of 13.6% at 5.8 years 2.

Related Questions

What is the recommended approach to diagnose and manage primary hyperaldosteronism in a patient with resistant hypertension and hypokalemia?
According to the 2025 hypertension guidelines, should the work‑up for resistant hypertension include screening for primary aldosteronism even when potassium levels are normal, and is renal denervation now considered an adjunctive option for selected patients?
What is the appropriate evaluation and management for a 54-year-old male with primary hyperaldosteronism presenting with heat‑induced palpitations and generalized weakness?
How should I manage a patient with marked alkalemia (pH 7.61), severe respiratory alkalosis (PaCO₂ 16 mmHg), mild metabolic acidosis (bicarbonate 16.7 mmol/L, anion gap ~18), hypoxemia (PaO₂ 62 mmHg on room air, SpO₂ 96%) and normal lactate?
Does a 71-year-old man with obstructive uropathy, severe renal failure, severe metabolic acidosis, marked hyperphosphatemia, and borderline hyperkalemia require emergent dialysis?
In a patient with resistant hypertension and palpitations, which laboratory tests (urine fractionated metanephrines, plasma free metanephrines, plasma renin activity, and cortisol) should be obtained to evaluate for secondary causes?
In a 12-year-old female who completed a 10‑day course of penicillin for streptococcal pharyngitis and now presents with cough, rhinorrhea, mild sore throat, non‑exudative pharyngitis, and a positive rapid antigen test for group A Streptococcus, how should she be managed?
What daily caloric intake and macronutrient distribution are needed for a 54‑kg, 6‑ft tall athlete with extensive resistance and conditioning training to ensure a surplus for weight gain?
How should I manage a patient with acute hypercapnic respiratory acidosis (pH 7.21, PaCO₂ 63 mmHg, base excess +2.6), mild anemia (hemoglobin 10.2 g/dL) and hyponatremia (serum sodium 122 mmol/L)?
What is the appropriate management of hypocalcemia in patients with thyroid disease?
What is a detailed daily meal plan with gram and calorie breakdown for macros for a 54‑kg, 6‑ft athlete performing extensive resistance and conditioning work who needs a caloric surplus for weight gain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.